Skip to content
Biodatica
Start free

Investigator

Phillip A Doerfler

VERSITI BLOOD HEALTH, INC. · funded by NIDDK

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$558k

Summed across those awards.

First award
Sep 21, 2024

Latest Sep 8, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R03

    DNA damage responses to genome editing in hematopoietic stem cells

    $242k

    Sep 8, 2025NIDDKVERSITI BLOOD HEALTH, INC.NIH RePORTER · 11117343 (opens the source filing in a new tab)

  2. K01

    Defining the mechanisms of hemoglobin switching and genotoxicities associated with its manipulation

    $158k

    Sep 21, 2024NIDDKVERSITI BLOOD HEALTH, INC.NIH RePORTER · 11195974 (opens the source filing in a new tab)

  3. K01

    Defining the mechanisms of hemoglobin switching and genotoxicities associated with its manipulation

    $158k

    Sep 21, 2024NIDDKVERSITI BLOOD HEALTH, INC.NIH RePORTER · 11296886 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources